Protagonist Therapeutics, Inc.
PEPTIDE INHIBITORS OF INTERLEUKIN-23 AND THEIR USE TO TREAT INFLAMMATORY DISEASES
Last updated:
Abstract:
The present invention provides novel peptide inhibitors of interleukin-23, and related methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease, Crohn's disease and psoriasis.
Status:
Application
Type:
Utility
Filling date:
27 Jul 2017
Issue date:
5 Sep 2019